Successful treatment of idiopathic anaphylaxis in an adolescent

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 2, 2010, Pages 415-416

  Pitt, Tracy J ^a   Cisneros, Nestor ^a   Kalicinsky, Chrystyna ^a   Becker, Allan B ^a  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CETIRIZINE; DOXEPIN; OMALIZUMAB; RANITIDINE;

ADOLESCENT; ANAPHYLAXIS; BONE BIOPSY; CASE REPORT; CONSCIOUSNESS DISORDER; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEART PALPITATION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; LETTER; MOSAICISM; NAUSEA; PALLOR; PHOTOPHOBIA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; SWELLING; VOMITING;

EID: 77955921599     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.05.043     Document Type: Letter

References (3)

1. Carter MC, Robyn JA, Bressler PB, Walker JC, Shapiro GG, Metcalfe DD. Omali-zumab for the treatment of unprovoked anaphylaxis in patients with systemic mas- tocytosis. J Allergy Clin Immunol 2007;119:1550-1.
2. Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody, rhuMab-E25 Study Group. N Engl J Med 1999;341:1966-73.
3. Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S. Omalizumab-induced reductions in mast cell FcepsilonRI expression and function. J Allergy Clin Immunol 2004;114:527-30.